Lymphatic filariasis is a disabling tropical disease spread by mosquitoes that causes swelling of the limbs and genitals. It impacts over 120 million people worldwide and is targeted for global elimination by 2020. Mass drug administration of medications that interrupt transmission has protected millions from infection and succeeded in eliminating the disease in some regions of the Americas, but active transmission remains in parts of Brazil, Haiti, the Dominican Republic, and Guyana. Continued scale up of treatment and improved disease management are needed to achieve elimination goals.